Applied Therapeutics, Inc. (APLT)

Applied Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11.95	79.4	49.9	16.66	53.89	57.47
Short-Term Investments	-	-	-	13.92	26.94	39.36
Cash & Short-Term Investments	11.95	79.4	49.9	30.58	80.82	96.83
Cash Growth	-87.92%	59.12%	63.17%	-62.16%	-16.53%	149.21%
Other Current Assets	19.71	4.25	4.49	6.73	7.57	5.76
Total Current Assets	31.65	83.65	54.39	37.31	88.39	102.59
Net Property, Plant & Equipment	2.47	2.79	0.45	0.86	1.3	1.71
Other Long-Term Assets	0.25	0.25	-	0.2	0.2	0.2
Total Assets	34.37	86.69	54.83	38.36	89.89	104.51

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	4.8	4.43	1.74	4.53	9.46	0.64
Accrued Expenses	23.49	16.14	15.29	14.76	16.56	20.19
Current Portion of Leases	0.47	0.41	0.43	0.48	0.44	0.41
Other Current Liabilities	4.14	6.31	53.73	13.66	-	-
Total Current Liabilities	32.9	27.3	71.18	33.42	26.46	21.24
Long-Term Leases	2.03	2.39	0.04	0.41	0.89	1.33
Other Long-Term Liabilities	-	-	0.76	0.46	-	-
Total Long-Term Liabilities	2.03	2.39	0.8	0.88	0.89	1.33
Total Liabilities	34.94	29.69	71.98	34.3	27.35	22.57

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	0.04	0.04	0.01	0.01	0	0
Additional Paid-in Capital	635.76	631.18	451.43	352.83	328.96	242.78
Accumulated Other Comprehensive Income	-	-	-	0.05	-0.11	-0.11
Retained Earnings	-636.36	-574.21	-468.59	-348.82	-266.32	-160.73
Shareholders' Equity	-0.56	57.01	-17.15	4.06	62.54	81.94
Total Liabilities & Equity	34.37	86.69	54.83	38.36	89.89	104.51

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	2.5	2.8	0.47	0.89	1.33	1.74
Net Cash (Debt)	9.45	76.6	49.43	29.69	79.49	95.09
Net Cash Growth	-90.25%	54.97%	66.50%	-62.65%	-16.41%	158.29%
Net Cash Per Share	0.07	0.55	0.59	0.79	3.10	4.33
Book Value	-0.56	57.01	-17.15	4.06	62.54	81.94
Book Value Per Share	-0.00	0.41	-0.20	0.11	2.44	3.73
Tangible Book Value	-0.56	57.01	-17.15	4.06	62.54	81.94
Tangible Book Value Per Share	-0.00	0.41	-0.20	0.11	2.44	3.73

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Sep 30, 2025

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error